SCHEMBL13558486

SCHEMBL13558486

O=COC1(c2ccccc2)c2cc(Br)c(O)c(Br)c2Oc2c1cc(Br)c(O)c2Br

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT1 Q99873 1/20 0.50
ALDH1A1 P00352 2/20 0.42
MAPK1 P28482 2/20 0.42
CYP3A4 P08684 1/20 0.42
THRB P10828 1/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42
CASP1 P29466 1/20 0.42
BRCA1 P38398 1/20 0.42
RECQL P46063 1/20 0.42
HIF1A Q16665 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
PTPN11 Q06124 1/20 0.38
HSP90AA1 P07900 1/20 0.38
AKR1C1 Q04828 2/20 0.35
CRHBP P24387 1/20 0.32
CRHR2 Q13324 1/20 0.32
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14189664 0.76 ALDH1A1 (0.47) PRMT1ALDH1A1MAPK1CYP3A4THRB
SCHEMBL10169409 0.70 FTO (0.46) PRMT1ALDH1A1HPGDBRCA1RECQL
SCHEMBL12228681 0.67 SLC6A1 (0.43) MAPK1CYP3A4MEN1KMT2A
SCHEMBL8163979 0.67 PRMT1 (0.50) PRMT1ALDH1A1MAPK1CYP3A4THRB
Eosin SCHEMBL29381252 0.67 PRMT1 (1.00) PRMT1ALDH1A1MAPK1CYP3A4THRB
Eosin SCHEMBL29350830 0.67 PRMT1 (1.00) PRMT1ALDH1A1MAPK1CYP3A4THRB
Eosin SCHEMBL113395 0.67 PRMT1 (1.00) PRMT1ALDH1A1MAPK1CYP3A4THRB
Eosin SCHEMBL1436014 0.66 PRMT1 (0.97) PRMT1ALDH1A1MAPK1CYP3A4THRB
Eosin SCHEMBL16862387 0.66 PRMT1 (0.97) PRMT1ALDH1A1MAPK1CYP3A4THRB
Eosin SCHEMBL461913 0.66 PRMT1 (0.97) PRMT1ALDH1A1MAPK1CYP3A4THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120272990-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2012-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120272990-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 PRMT1 1981/4885ALDH1A1 192/4885MAPK1 3478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.